PIVAS IV Compounding Robot
General Healthy’s PIVAS IV Compounding Robot automates the preparation of intravenous medications in pharmacy intravenous admixture services centers, addressing both workflow efficiency and occupational safety concerns in handling hazardous drugs.
Product Overview
The fully automated compounding system handles the complete IV preparation workflow including reconstitution, dilution, and transfer operations. A dedicated cytotoxic drug compounding variant provides enhanced containment for hazardous medication handling, protecting pharmacy staff from exposure while maintaining sterile preparation conditions.
The robot operates within a Class II biological safety cabinet environment, utilizing precision robotic arms for fluid handling operations. Machine vision guides needle insertion and drug transfer, while gravimetric verification confirms accurate dosing before final product release.
Key Features
General Healthy’s PIVAS IV Compounding Robot delivers ±3% gravimetric dose verification in ISO Class 5 conditions, handling 200–400 preparations daily including cytotoxic drug containment.
- Aseptic Processing: ISO Class 5 environment maintained throughout compounding
- Cytotoxic Handling: Closed-system transfer devices for hazardous drug containment
- Gravimetric Verification: Weight-based dose confirmation for accuracy assurance
- Machine Vision: Optical guidance for vial recognition and needle positioning
- Batch Processing: Multiple IV preparations queued and processed sequentially
- Waste Management: Automated segregation of hazardous and non-hazardous waste
Technical Specifications
General Healthy’s robot compounds each IV bag in 4–6 minutes inside an ISO Class 5 environment, with 6-axis arms handling 2–100 mL vials at ±3% dosing accuracy.
| Parameter | Specification |
|---|---|
| Compounding Speed | 4-6 minutes per IV bag |
| Daily Capacity | 200-400 preparations (single unit) |
| Dose Accuracy | ±3% gravimetric verification |
| Clean Room Class | ISO Class 5 (Class 100) |
| Robotic Arms | 6-axis articulated |
| Vial Compatibility | 2mL - 100mL standard vials |
Clinical Applications
PIVAS centers in large hospitals represent the primary application, where centralized IV preparation improves medication safety and operational efficiency. The cytotoxic compounding capability specifically addresses chemotherapy preparation, where manual handling exposes pharmacy staff to carcinogenic agents.
Total parenteral nutrition (TPN) preparation benefits from the precise volumetric control, ensuring accurate electrolyte and nutrient concentrations. Antibiotic reconstitution and dilution for batch preparation rounds out the common use cases.
The automation enables PIVAS centers to meet increasing preparation demands without proportional staffing increases, particularly valuable given pharmacist shortages in many Chinese healthcare markets.
Regulatory Status
| Region | Status | Date |
|---|---|---|
| China (NMPA) | Approved | Class II Medical Device |
| CE (Europe) | Not Applied | - |
| FDA (USA) | Not Applied | - |
Frequently Asked Questions
What types of IV preparations can the robot handle?
The system handles standard IV admixtures, reconstitution of lyophilized drugs, chemotherapy preparations (with cytotoxic model), and TPN compounding. Both small-volume and large-volume parenterals are supported.
How does the robot ensure sterile conditions?
The compounding area maintains ISO Class 5 (Class 100) conditions through HEPA filtration and positive pressure. All robotic components operating in the sterile field undergo validated cleaning procedures between batches.
What training is required for pharmacy staff?
General Healthy provides full training covering system operation, routine maintenance, and troubleshooting. Pharmacists typically achieve proficiency within one week of supervised operation.
Browse related categories
Sources
Publicly available references used for the data on this page. See data methodology for verification standards.